Brainstorm Cell Therapeutics Inc. is perceived as one of Flex Pharma's biggest rivals. Brainstorm Cell Therapeutics Inc.'s headquarters is in New York, New York, and was founded in 2000. Brainstorm Cell Therapeutics Inc. operates in the Biotechnology industry. Brainstorm Cell Therapeutics Inc. generates 43% of Flex Pharma's revenue.
Prana Biotechnology has been one of Flex Pharma's top competitors. Prana Biotechnology is a Public company that was founded in 1997 in Parkville, Victoria. Prana Biotechnology operates in the Pharmaceuticals industry. Compared to Flex Pharma, Prana Biotechnology has 7 more employees.
Flex Pharma's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 67.4M. Over the last two quarters, Flex Pharma's revenue has decreased by 12.4%. Specifically, in Q1 2020's revenue was $1.1M; in Q4 2019, it was $1.3M.
No recent acquisitions found related to Flex Pharma
Since Flex Pharma was founded in 2014, it has participated in 3 rounds of funding. In total Flex Pharma has raised $142.6M. Flex Pharma's last funding round was on Jan 2015 for a total of $86.4M
No recent investments found related to Flex Pharma